Authors work in the area has been supported by UK Medical Research Council Experimental Medicine Grant (G0502131), the National Institute for Health Research and a UK Medical Research Council Clinical Research Training Fellowship (AR -MR/K002406/1). AR is supported by a Wellcome Trust Clinical Research Career Development Fellowship 206632/Z/17/Z.Publisher PDFPeer reviewe
Abstract Inflammation has been long regarded as a key contributor to atherosclerosis....
Dyslipidaemia and inflammation are closely interconnected in their contribution to atherosclerosis. ...
Inflammation is a critical pathway in the pathogenesis of atherosclerosis. Previous studies have sho...
BACKGROUND: Experimental and clinical data suggest that reducing inflammation without affecting lipi...
IL-1 cytokines are mainly responsible for controlling a series of pro-inflammatory reactions induced...
The hypothesis of an inflammatory component in the pathogenesis of atherosclerosis has been under in...
Background Inflammation contributes to all phases of the atherothrombotic process, and patients with...
The CANTOS trial (Canakinumab Anti-Inflammatory Thrombosis Outcome Study) provides intriguing suppor...
BACKGROUND: Experimental and clinical data suggest that reducing inflammation without affecting lipi...
Atherosclerosis is a chronic inflammatory disorder of the vasculature where cholesterol accumulates ...
The outcomes of the Canakinumab Anti-inflammatory Thrombosis Outcome Study (CANTOS) trial have unequ...
Atherosclerosis is still a great burden on human health and scientific achievements of the past 30 y...
Over more than two decades, the concept of atherosclerosis has developed and lead to inflammatory hy...
Abstract Inflammation has been long regarded as a key contributor to atherosclerosis....
Dyslipidaemia and inflammation are closely interconnected in their contribution to atherosclerosis. ...
Inflammation is a critical pathway in the pathogenesis of atherosclerosis. Previous studies have sho...
BACKGROUND: Experimental and clinical data suggest that reducing inflammation without affecting lipi...
IL-1 cytokines are mainly responsible for controlling a series of pro-inflammatory reactions induced...
The hypothesis of an inflammatory component in the pathogenesis of atherosclerosis has been under in...
Background Inflammation contributes to all phases of the atherothrombotic process, and patients with...
The CANTOS trial (Canakinumab Anti-Inflammatory Thrombosis Outcome Study) provides intriguing suppor...
BACKGROUND: Experimental and clinical data suggest that reducing inflammation without affecting lipi...
Atherosclerosis is a chronic inflammatory disorder of the vasculature where cholesterol accumulates ...
The outcomes of the Canakinumab Anti-inflammatory Thrombosis Outcome Study (CANTOS) trial have unequ...
Atherosclerosis is still a great burden on human health and scientific achievements of the past 30 y...
Over more than two decades, the concept of atherosclerosis has developed and lead to inflammatory hy...
Abstract Inflammation has been long regarded as a key contributor to atherosclerosis....
Dyslipidaemia and inflammation are closely interconnected in their contribution to atherosclerosis. ...
Inflammation is a critical pathway in the pathogenesis of atherosclerosis. Previous studies have sho...